Myeloid-derived-suppressor cells as regulators of the immune system

Cited by (1,052)

Items 501–600 of 1,052

1. Crucial Role of Granulocytic Myeloid-Derived Suppressor Cells in the Regulation of Central Nervous System Autoimmune Disease
   Μαριάννα Ιωάννου, Themis Alissafi, Iakovos Lazaridis, George Deraos, John Matsoukas, Achille Gravanis, Vasileios C. Mastorodemos, Andreas Plaitakis, Arlene H. Sharpe, Dimitrios T. Boumpas et al. · 2011 · The Journal of Immunology
2. Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune Diseases
   Xu Wang, Lin Qiu, Ziyi Li, Xiang‐Yang Wang, Huanfa Yi · 2018 · Frontiers in Immunology
3. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
   Konstantina Georgila, Dimitra Vyrla, Elias Drakos · 2019 · Cancers
4. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells
   Ning‐Ning Liu, Chengxiang Yi, Luqi Wei, Jin‐An Zhou, Tong Jiang, Cong-Cong Hu, Lu Wang, Yuan-Yuan Wang, Yun Zou, Yi-Kai Zhao et al. · 2023 · Cancer Cell
5. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
   Luca Cassetta, Espen S. Bækkevold, Sven Brandau, Anna Bujko, Marco Antonio Cassatella, Anca Dorhoi, Carsten Krieg, Ang Lin, Karin Loré, Olivia Marini et al. · 2019 · Cancer Immunology Immunotherapy
6. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice
   Éva Hadadi, William R. Taylor, Xiaomei Li, Yetki Aslan, Marthe Vilotte, Julie Rivière, Gaelle Duvallet, Charlotte Auriau, Sandrine Dulong, Isabelle Raymond‐Letron et al. · 2020 · Nature Communications
7. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
   Schneider, Kai Markus, Mohs, Antje, Gui, Wenfang, Galvez, Eric J. C., Candels, Lena Susanna, Hoenicke, Lisa, Muthukumarasamy, Uthayakumar, Holland, Christian H., Elfers, Carsten, Kilic, Konrad et al. · 2022 · Nature Communications
8. Engineering Approaches to Immunotherapy
   Melody A. Swartz, Sachiko Hirosue, Jeffrey A. Hubbell · 2012 · Science Translational Medicine
9. Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
   Yiyi Yan, Anagha Bangalore Kumar, Heidi Diann Finnes, Svetomir N. Markovic, Sean S. Park, Roxana Stefania Dronca, Haidong Dong · 2018 · Frontiers in Immunology
10. Overcoming Immune Evasion in Melanoma
    Kevinn Eddy, Suzie Chen · 2020 · International Journal of Molecular Sciences
11. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
    Sahar Mafi, Behzad Mansoori, Shahram Taeb, Hossein Sadeghi, Reza Abbasi, William Chi Shing Cho, Davoud Rostamzadeh · 2022 · Frontiers in Immunology
12. S100A9 a new marker for monocytic human myeloid‐derived suppressor cells
    Fei Zhao, Bastian Hoechst, Austin G. Duffy, Jaba Gamrekelashvili, Suzanne Fioravanti, Michael Peter Manns, Tim F. Greten, Firouzeh Korangy · 2012 · Immunology
13. Myeloid-Derived Suppressor Cells in Human Cancer
    Srinivas Nagaraj, Dmitry I. Gabrilovich · 2010 · The Cancer Journal
14. The split personality of regulatory T cells in HIV infection
    Mathieu F. Chevalier, Laurence Weiss · 2012 · Blood
15. The role of cancer-derived microRNAs in cancer immune escape
    Yi, Ming, Xu, Linping, Jiao, Ying, Luo, Suxia, Li, Anping, Wu, Kongming · 2020 · Journal of Hematology & Oncology
16. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
    Ryan A. Wilcox, Andrew L. Feldman, David A. Wada, Zhi‐Zhang Yang, Nneka I. Comfere, Haidong Dong, Eugene D. Kwon, Anne Josephine Novak, Svetomir N. Markovic, Mark R. Pittelkow et al. · 2009 · Blood
17. Phenotype, development, and biological function of myeloid-derived suppressor cells
    Yang Zhao, Tingting Wu, Steven Shao, Bingyi Shi, Yong Xiang Zhao · 2015 · OncoImmunology
18. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis
    Erik Thiele Orberg, Hongni Fan, Ada J Tam, Christine M. Dejea, Christina E. DeStefano Shields, Shaoguang Wu, Liam Chung, Benjamin B. Finard, Xinqun Wu, Parinaz Fathi et al. · 2016 · Mucosal Immunology
19. ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence
    Mathieu F. Chevalier, Sara Trabanelli, Julien Racle, Bérengère Salomé, Valérie Cesson, Dalila Gharbi, Perrine Bohner, Sonia Domingos‐Pereira, Florence Dartiguenave, Anne-Sophie Fritschi et al. · 2017 · Journal of Clinical Investigation
20. Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
    Coffelt, Seth B, Chen, Yung-Yi, Muthana, Munitta, Welford, Abigail F, Tal, Andrea O, Scholz, Alexander, Plate, Karl H, Reiss, Yvonne, Murdoch, Craig, De Palma, Michele et al. · 2011 · The Journal of Immunology
21. Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
    Emma Eriksson, Jessica Wenthe, Sandra Irenaeus, Angelica Loskog, Gustav Jörgen Ullenhag · 2016 · Journal of Translational Medicine
22. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
    Baohua Li, Malgorzata Anna Garstka, Zongfang Li · 2019 · Molecular Immunology
23. Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
    Jinpu Yu, Yue Wang, Yan Fang, Peng Zhang, Hui Li, Hua Zhao, Cihui Yan, Yan Liang Fan, Xiubao Ren · 2014 · The Journal of Immunology
24. Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival
    Inge H. G. Bronkhorst, Long V. Ly, Ekaterina S. Jordanova, J. Vrolijk, Mieke Versluis, Gregorius P. M. Luyten, Martine Johanna Jager · 2010 · Investigative Ophthalmology & Visual Science
25. Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen
    Stefano Ugel, Elisa Peranzoni, Giacomo Desantis, Mariacristina Chioda, Steffen Walter, Toni Weinschenk, Jordi Ochando, Anna Cabrelle, Susanna Mandruzzato, Vincenzo Bronte · 2012 · Cell Reports
26. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
    João Conniot, Anna Scomparin, Carina Peres, Eilam Yeini, Sabina Pozzi, Ana I. Matos, Ron Kleiner, Liane I.F. Moura, Eva Zupančič, Ana S. Viana et al. · 2019 · Nature Nanotechnology
27. Neutrophils as potential therapeutic targets in hepatocellular carcinoma
    Daniel Geh, Jack Leslie, Rob Rumney, Helen Louise Reeves, Thomas Graham Bird, Derek A. Mann · 2022 · Nature Reviews Gastroenterology & Hepatology
28. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations
    Linda J. Wammes, Harriet Mpairwe, Alison M. Elliott, Maria Yazdanbakhsh · 2014 · The Lancet Infectious Diseases
29. TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
    Kirill V. Korneev, Kamar‐Sulu N. Atretkhany, Marina S. Drutskaya, Sergei I. Grivennikov, Dmitry V. Kuprash, Sergei A. Nedospasov · 2016 · Cytokine
30. Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function
    Merav E. Shaul, Zvi Gregorio Fridlender · 2018 · FEBS Journal
31. Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells
    Yuelong Liu, Xiaoyu Xiang, Xiaoying Zhuang, Shuangyin Zhang, Cunren Liu, Ziqiang Cheng, Sue Michalek, William E. Grizzle, Huang‐Ge Zhang · 2010 · American Journal Of Pathology
32. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
    Thomas Welte, Ik Sun Kim, Lin Hai Tian, Xia Gao, Hai Wang, June Li, Xue B. Holdman, Jason I. Herschkowitz, Adam C. Pond, Guorui Xie et al. · 2016 · Nature Cell Biology
33. Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
    Mélanie Desbois, Yulei Wang · 2021 · Immunological Reviews
34. Chemokines in cancer related inflammation
    Paola Allavena, Giovanni Germano, Federica Marchesi, Alberto Mantovani · 2010 · Experimental Cell Research
35. Cytokine-Induced Modulation of Colorectal Cancer
    Lukas Franz Mager, Marie-Hélène Wasmer, Tilman T. Rau, Philippe Krebs · 2016 · Frontiers in Oncology
36. Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
    Marie Klinge Brimnes, Annette Juul Vangsted, Lene Meldgaard Knudsen, Peter Gimsing, Anne Ortved Gang, Hans Erik Johnsen, Inge Marie Svane · 2010 · Scandinavian Journal of Immunology
37. STAT3 activation
    Cédric Rébé, Frédérique Végran, Hélène Berger, François Ghiringhelli · 2013 · JAK-STAT
38. Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
    Minu K. Srivastava, Li Xin Zhu, Marni E. Harris‐White, Upendra K. Kar, Min Huang, Ming F. Johnson, Jay M. Lee, David A. Elashoff, Robert M. Strieter, Steven M. Dubinett et al. · 2012 · PLoS ONE
39. The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC)
    Debasish Basak, Mohammad Nasir Uddin, Jake Hancock · 2020 · Cancers
40. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
    Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt, Jonathan B. Mitchem, Lori A. Worley, Brian D. Goetz, Pinku Mukherjee, Andrea Wang‐Gillam, Daniel C. Link, David G. DeNardo et al. · 2014 · Cancer Immunology Immunotherapy
41. Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid derived suppressor cells with a selective inhibitor of PI3Kδ/γ
    Ruth J. Davis, E. Moore, Paul E. Clavijo, J. Friedman, Harrison A. Cash, Zhong Chen, Christopher Silvin, C. Van Waes, C. Allen · 2017 · Cancer Research
42. Surgical trauma‐induced immunosuppression in cancer: Recent advances and the potential therapies
    Tang, Fan, Tie, Yan, Tu, Chongqi, Wei, Xiawei · 2020 · Clinical and Translational Medicine
43. Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
    Luca Antonioli, Gennady G. Yegutkin, Pál Pacher, Corrado Blandizzi, György Haskó · 2016 · Trends in cancer
44. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
    Étienne Becht, Nicolás A. Giraldo, Claire Germain, Aurélien de Reyniès, Pierre Laurent‐Puig, Jessica Zucman‐Rossi, Marie‐Caroline Dieu‐Nosjean, Catherine Sautès‐Fridman, Wolf H. Fridman · 2016 · Advances in immunology
45. Emerging strategies for combination checkpoint modulators in cancer immunotherapy
    Aleksandra Popović, Elizabeth M. Jaffee, Neeha Zaidi · 2018 · Journal of Clinical Investigation
46. Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
    Wang, Yungang, Yin, Kai, Tian, Jie, Xia, Xueli, Ma, Jie, Tang, Xinyi, Xu, Huaxi, Wang, Shengjun · 2019 · Advanced Science
47. Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
    Thomas Vogl, Anna L. Gharibyan, Ludmilla A. Morozova‐Roche · 2012 · International Journal of Molecular Sciences
48. Type I Interferon Signaling Regulates Ly6Chi Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
    Sang‐Uk Seo, Hyung-Joon Kwon, Hyun-Jeong Ko, Young-Ho Byun, Baik Lin Seong, Satoshi Uematsu, Shizuo Akira, Mi‐Na Kweon · 2011 · PLoS Pathogens
49. Antitumor Platelet‐Mimicking Magnetic Nanoparticles
    Lang Rao, Lin‐Lin Bu, Qian‐Fang Meng, Bo Cai, Wei‐Wei Deng, Andrew Li, Kaiyang Li, Shishang Guo, Wen‐Feng Zhang, Wei Liu et al. · 2017 · Advanced Functional Materials
50. Emerging role of PTEN loss in evasion of the immune response to tumours
    Thiago Vidotto, Camila Morais Melo, Erick C. Castelli, Madhuri Koti, Rodolfo Borges dos Reis, Jeremy Andrew Squire · 2020 · British Journal of Cancer
51. Maternal Microbiota, Early Life Colonization and Breast Milk Drive Immune Development in the Newborn
    Cristina Kalbermatter, Nerea Fernandez Trigo, Sandro Christensen, Stephanie Christine Ganal-Vonarburg · 2021 · Frontiers in Immunology
52. Monocytes and Macrophages in Cancer: Development and Functions
    David M. Richards, Jan Hettinger, Markus Feuerer · 2012 · Cancer Microenvironment
53. Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
    Ang Huang, Bo Zhang, Bo Wang, Fan Zhang, Kexing Fan, Yajun Guo · 2013 · Cancer Immunology Immunotherapy
54. Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
    Indu R Ramachandran, Anna Martner, Alexandra Pisklakova, Thomas Condamine, Tess Chase, Thomas Vogl, Johannes Roth, Dmitry I. Gabrilovich, Yulia Nefedova · 2013 · The Journal of Immunology
55. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
    Matthew Dysthe, Robin Parihar · 2020 · Advances in experimental medicine and biology
56. Myeloid‐derived suppressor cells in cancer: recent progress and prospects
    Yazan S. Khaled, Basil J. Ammori, Eyad Elkord · 2013 · Immunology and Cell Biology
57. Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
    Melissa G. Lechner, Carolina Megiel, Sarah May Russell, Brigid Bingham, N. Arger, Tammy T. Woo, Alan L. Epstein · 2011 · Journal of Translational Medicine
58. Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
    Ian F. Pollack, Regina I. Jakacki, Lisa Helene Butterfield, Ronald L. Hamilton, Ashok Panigrahy, Douglas M. Potter, Angela K. Connelly, Sharon Dibridge, Theresa L. Whiteside, Hideho Okada · 2014 · Journal of Clinical Oncology
59. Mice That Express Human Interleukin-8 Have Increased Mobilization of Immature Myeloid Cells, Which Exacerbates Inflammation and Accelerates Colon Carcinogenesis
    Samuel Asfaha, Alexander N. Dubeykovskiy, Hiroyuki Tomita, Xiangdong Yang, Sarah Stokes, Wataru Shibata, Richard A. Friedman, Hiroshi Ariyama, Zinaida A. Dubeykovskaya, Sureshkumar Muthupalani et al. · 2012 · Gastroenterology
60. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
    A. Farina, A. Mackay · 2014 · Cancers
61. A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects
    Jose G. Gomez‐Arroyo, Sheinei J. Saleem, Shiro Mizuno, Aamer A. Syed, Harm Jan Bogaard, Antonio Abbate, Laimute Taraseviciene‐Stewart, Yon K. Sung, Donatas Kraskauskas, Daniela Farkas et al. · 2012 · American Journal of Physiology-Lung Cellular and Molecular Physiology
62. Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity
    Louise Elliott, Glen A. Doherty, Kieran D. Sheahan, Elizabeth J. Ryan · 2017 · Frontiers in Immunology
63. Combinations of Bevacizumab With Cancer Immunotherapy
    Daniel S. Chen, Herbert I. Hurwitz · 2018 · The Cancer Journal
64. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
    Sara K. Daniel, Kevin M. Sullivan, Kevin P. Labadie, Venu Gopal Pillarisetty · 2019 · Clinical and Translational Medicine
65. Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
    Christina Lynn Roland, Kristi D. Lynn, Jason E. Toombs, Sean Patrick Dineen, D. Gomika Udugamasooriya, Rolf A. Brekken · 2009 · PLoS ONE
66. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
    Christel Devaud, Liza B. John, Jennifer A. Westwood, Phillip Kevin Darcy, Michael H. Kershaw · 2013 · OncoImmunology
67. Therapeutic targeting of myeloid-derived suppressor cells
    Stefano Ugel, Federica Delpozzo, Giacomo Desantis, Francesca Papalini, Francesca Simonato, Nada Sonda, Serena Zilio, Vincenzo Bronte · 2009 · Current Opinion in Pharmacology
68. VISTA expressed in tumour cells regulates T cell function
    Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ken D Yamaguchi, Naoki Horikawa, Ryusuke Murakami et al. · 2018 · British Journal of Cancer
69. Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer
    Evgeniy B. Eruslanov, Molly M. Neuberger, Irina Daurkin, George Q. Perrin, Chester B. Algood, Philipp Dahm, Charles Joel Rosser, Johannes Vieweg, Scott Michael Gilbert, Sergei A. Kusmartsev · 2011 · International Journal of Cancer
70. Tim-3, a negative regulator of anti-tumor immunity
    Ana Carrizosa Anderson · 2012 · Current Opinion in Immunology
71. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice
    Mercedes Rodriguez Garcia, Levi G. Ledgerwood, Yu Yang, Jiangnan Xu, Girdhari Lal, Bryna E. Burrell, Ge Ma, Daigo Hashimoto, Yansui Li, Péter Boros et al. · 2010 · Journal of Clinical Investigation
72. Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
    Xian-De Liu, Anh G. Hoang, Lijun Zhou, Sarathi Kalra, Alper Yetil, Mianen Sun, Zhiyong Ding, Xuesong Zhang, Shanshan Bai, Péter Germán et al. · 2015 · Cancer Immunology Research
73. Neutrophils in cancer
    Louise W. Treffers, Ida H. Hiemstra, Taco Willem Kuijpers, Timo K. van den Berg, Hanke L. Matlung · 2016 · Immunological Reviews
74. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
    Arya Biragyn, Luigi Ferrucci · 2018 · The Lancet Oncology
75. Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
    Sade-Feldman, Moshe, Kanterman, Julia, Klieger, Yair, Ish-Shalom, Eliran, Olga, Mizrahi, Saragovi, Amijai, Shtainberg, Hani, Lotem, Michal, Baniyash, Michal · 2016 · Clinical Cancer Research
76. Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
    Yongkui Li, Min Fang, Jian Zhang, Jian Wang, Yu Song, Jie Shi, Wei Li, Gang Wu, Jinghua Ren, Zheng Wang et al. · 2015 · OncoImmunology
77. Immune Cell Phenotype and Function in Sepsis
    Thomas R. Rimmele, Didier M. Payen, Vincenzo Cantaluppi, John C. Marshall, Hernando Gómez, Alonso Gómez, Patrick T. Murray, John A. Kellum · 2015 · Shock
78. Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration
    Changrong Shi, Ting Liu, Zhide Guo, Rongqiang Zhuang, Xianzhong Zhang, Xiaoyuan Shawn Chen · 2018 · Nano Letters
79. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
    Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczyńska-Moncznik, Oktawia Osiecka, Xiaoying Hu, Ida Marie Rundgren, Ang Lin, Kim C. M. Santegoets, Utku Horzum, Ana Godinho‐Santos et al. · 2020 · Journal for ImmunoTherapy of Cancer
80. S100 protein family in human cancer.
    Hongyan Chen, Chengshan Xu, Qing'e Jin, Zhihua Liu · 2014 · Europe PMC (PubMed Central)
81. Myeloid-derived Suppressor Cells in Cancer Patients
    Alberto J. Montero, Claudia Marcela Diaz-Montero, Christos E. Kyriakopoulos, Vincenzo Bronte, Susanna Mandruzzato · 2012 · Journal of Immunotherapy
82. Signaling pathways involved in MDSC regulation
    Prashant Trikha, William Edgar Carson · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
83. The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells
    Tingting Wang, Chaogang Fan, Anran Yao, Xingwei Xu, Guoxing Zheng, Yun You, Changying Jiang, Xueqiang Zhao, Yayi Hou, Mien‐Chie Hung et al. · 2018 · Immunity
84. Intermittent Hypoxia-induced Changes in Tumor-associated Macrophages and Tumor Malignancy in a Mouse Model of Sleep Apnea
    Almendros, Isaac, Wang, Yang, Becker, Lev, Lennon, Frances E., Zheng, Jiamao, Coats, Brittney R., Schoenfelt, Kelly S., Carreras, Alba, Hakim, Fahed, Zhang, Shelley X. et al. · 2014 · American Journal of Respiratory and Critical Care Medicine
85. The Role of Complement in Tumor Growth
    Rubén Pı́o, Leticia P. Corrales, John D. Lambris · 2013 · Advances in experimental medicine and biology
86. Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
    Surya Kumari Vadrevu, Navin K. Chintala, Sharad Sharma, Priya Sharma, Clayton Cleveland, Linley Riediger, Sasikanth Manne, David P. Fairlie, Wojciech Gorczyca, Othon Almanza et al. · 2014 · Cancer Research
87. Lymphangiogenesis and Cancer
    Ailsa J. Christiansen, Michael J. Detmar · 2011 · Genes & Cancer
88. Inflammatory networks and immune surveillance of pancreatic carcinoma
    Robert H. Vonderheide, Lauren J. Bayne · 2013 · Current Opinion in Immunology
89. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
    Giuseppe Sammarco, Gilda Varricchi, Valentina Ferraro, Michele Ammendola, Michele De Fazio, Donato F. Altomare, Maria Luposella, Lorenza Maltese, Giuseppe Currò, Gianni Marone et al. · 2019 · International Journal of Molecular Sciences
90. Hypoxia-inducible factors: a central link between inflammation and cancer
    Triner, Daniel, Shah, Yatrik M. · 2016 · Journal of Clinical Investigation
91. SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1 α –Dependent Glycolysis
    Guangwei Liu, Yujing Bi, Bo Shen, Hui Yang, Yan Zhang, Xiao Wang, Huanrong Liu, Yun Lu, Jiongbo Liao, Xi Chen et al. · 2013 · Cancer Research
92. The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
    Elizabeth A. Vasievich, Leaf Huang · 2011 · Molecular Pharmaceutics
93. A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
    Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish Ramesh Patel, Holbrook E K Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary Lenora Disis, Judith C. Kaiser et al. · 2017 · Clinical Cancer Research
94. Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells
    Gencheng Han, Guojiang Chen, Beifen Shen, Yan Li · 2013 · Frontiers in Immunology
95. Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I
    Trisha R. Sippel, Jason White, Kamalika Nag, Vadim Tsvankin, Marci Klaassen, Bette Kay Kleinschmidt-DeMasters, Allen E. Waziri · 2011 · Clinical Cancer Research
96. Myeloid-Derived Suppressor Cells Contribute to Staphylococcus aureus Orthopedic Biofilm Infection
    Cortney E. Heim, Debbie Vidlak, Tyler D. Scherr, Jessica A. Kozel, Melissa S. Holzapfel, David E. Muirhead, Tammy Kielian · 2014 · The Journal of Immunology
97. The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
    Jennifer Huynh, Nima Etemadi, Frédéric Hollande, Matthias Ernst, Michael Büchert · 2017 · Seminars in Cancer Biology
98. Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
    Elisabeth Seebach, Katharina F. Kubatzky · 2019 · Frontiers in Immunology
99. Cancer Vaccines, Adjuvants, and Delivery Systems
    Paston, Samantha J., Brentville, Victoria A., Symonds, Peter, Durrant, Lindy G. · 2021 · Frontiers in Immunology
100. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
     Kong, Miao, Tang, Jiamin, Qiao, Qi, Wu, Tingting, Qi, Yan, Tan, Songwei, Gao, Xueqin, Zhang, Zhiping · 2017 · Theranostics